Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&lookfor=%22antibodies%22&type=Subject&page=8
/vufind/Search/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&lookfor=%22antibodies%22&type=Subject&page=8
Search /vufind/Search2/Results?filter%5B%5D=%23%3A%22%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29%22&lookfor=%22antibodies%22&type=Subject&page=8
PubPharm (22.927)
71
Inhibition of PCSK9 with evolocumab modulates lipoproteins and monocyte activation in high-risk ASCVD subjects
enthalten in:
Atherosclerosis
| 2024
von
Rosenson, R.
|
Tate, A.
|
Mar, P.
| +3
Wird geladen...
72
Efficacy, Safety, and Pharmacokinetics of AZD7442 (Tixagevimab/Cilgavimab) for Prevention of Symptomatic COVID-19 : 15-Month Final Analysis of the PROVENT and STORM CHASER Trials
enthalten in:
Infectious diseases and therapy
| 2024
von
Levin, M.
|
Ustianowski, A.
|
De Wit, S.
| +8
Wird geladen...
73
Tocilizumab for refractory post-COVID-19 pansclerotic morphea
enthalten in:
Journal of the European Academy of Dermatology and Venereology : JEADV
| 2024
von
Saraswat, N.
|
Tripathy, D.
|
Mishra, A.
| +3
Wird geladen...
74
Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination : implications of immune imprinting and interference
enthalten in:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
| 2024
von
Choi, M.
|
Yu, Y.
|
Kim, J.
| +13
Wird geladen...
75
Proteomics Platform Reveals Broad-Spectrum Nanobodies for SARS-CoV-2 Variant Neutralization
enthalten in:
Journal of proteome research
| 2024
von
Zhang, R.
|
Huang, L.
|
Zhang, X.
| +9
Wird geladen...
76
Screening and Analysis of SARS-CoV-2 Antibody Among Unvaccinated Blood Donors in Chongqing, China
enthalten in:
Disaster medicine and public health preparedness
| 2024
von
Jiang, Y.
|
Huang, L.
|
Liao, H.
| +3
Wird geladen...
77
Adjuvant-dependent impact of inactivated SARS-CoV-2 vaccines during heterologous infection by a SARS-related coronavirus
enthalten in:
Nature communications
| 2024
von
Dillard, J.
|
Taft-Benz, S.
|
Knight, A.
| +28
UpdateOf: Res Sq. 2023 Oct 27;:. - PMID 37961507
Wird geladen...
78
Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients : a systematic review and meta-analysis
enthalten in:
Virology journal
| 2024
von
Sharifi Aliabadi, L.
|
Azari, M.
|
Taherian, M.
| +7
Wird geladen...
79
A case of hypophysitis after COVID-19 vaccination with a detection of anti-pituitary antibody, with review of literature
enthalten in:
Endocrine journal
| 2024
von
Kyo, C.
|
Kobayashi, T.
|
Iwama, S.
| +9
Wird geladen...
80
Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease : Data from ESCAPE-IBD, an IG-IBD Study
enthalten in:
Inflammatory bowel diseases
| 2024
von
Macaluso, F.
|
Principi, M.
|
Facciotti, F.
| +45
Wird geladen...
[1]
« Vorheriger
3
4
5
6
7
8
9
10
11
12
13
Nächster »
[2293]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
22.916
Aufsätze
22.445
E-Ressourcen
22.434
E-Artikel
482
Gedruckte Aufsätze
11
Bücher
11
E-Books
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
863
Frontiers in immunology
671
Vaccines
665
Viruses
441
Journal of medical virology
373
Nature communications
351
Frontiers in Immunology
337
Scientific reports
327
PloS one
288
Vaccine
240
The Journal of infectious diseases
209
International journal of infectious diseases : ...
201
Clinical infectious diseases : an official publ...
198
BMC infectious diseases
192
The Journal of infection
178
Emerging microbes & infections
174
The New England journal of medicine
168
EBioMedicine
165
Microbiology spectrum
162
International journal of molecular sciences
150
Nature
Alle anzeigen ...
weniger ...
Thema
16.563
Journal Article
11.531
Antibodies, Viral
8.964
SARS-CoV-2
8.911
COVID-19
6.808
Research Support, Non-U.S. Gov't
5.323
Antibodies, Neutralizing
4.834
COVID-19 Vaccines
3.612
Spike Glycoprotein, Coronavirus
3.611
Immunoglobulin G
3.110
spike protein, SARS-CoV-2
1.792
Research Support, N.I.H., Extramural
1.681
Review
1.616
BNT162 Vaccine
1.583
Letter
1.568
Antibodies, Monoclonal
1.523
Antibodies, Monoclonal, Humanized
1.281
antibodies
1.081
Antibodies
1.054
Immunoglobulin M
1.028
N38TVC63NU
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
22.615
2020-
133
2010-2019
161
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22.565
Englisch
78
Deutsch
75
Russisch
60
Chinesisch
56
Spanisch
40
Französisch
22
Türkisch
14
Japanisch
9
Ungarisch
8
Italienisch
7
Polnisch
6
Koreanisch
6
Portugiesisch
5
Persisch
4
Niederländisch
3
Schwedisch
3
Ukrainisch
3
Unbestimmt
1
Hindi
1
Isländisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...